COL3A1 overexpression has been confirmed in multiple cancers, such as bladder cancer, while the impact of COL3A1 expression level in GC is not completely understood (Gao et al., 2016; Liu et al., 2018; Yuan et al., 2017). The gene discussed is COL3A1; the disease is urinary bladder cancer.